External Resources:

Director Announcement

UCSD Campus Notice

University of California San Diego Health Sciences

Date: Monday, March 4, 2013
To: UCSD Health Sciences Faculty
From: David A. Brenner, MD
Vice Chancellor for Health Sciences and
Dean, School of Medicine
SUBJECT: Institute for Genomic Medicine

I am extremely pleased to announce the appointment of Kelly A. Frazer, PhD, as the new director of the Institute for Genomic Medicine (IGM) effective March 1, 2013. Dr. Frazer is professor and founding chief of the Division of Genome Information Sciences in the Department of Pediatrics. Her research focus is on identifying genomic markers associated with complex diseases in children as well as across the lifespan. Before joining UC San Diego in 2009, Dr. Frazer was Professor of Translational Genomics at the Scripps Research Institute and, prior to that, Vice President of Genomic Biology at Perlegen Sciences.

Dr. Frazer will succeed Kang Zhang, MD, PhD, Professor of Ophthalmology, who served as the first director of the IGM. He will be returning full-time to the faculty to dedicate his time and energy to research, teaching and clinical activities. I wish to thank Dr. Zhang for his tireless efforts in launching IGM and directing its evolution over the past four years.

IGM will continue to galvanize our efforts in genetics and genomics, and ensure that UC San Diego remains at the forefront of basic and translational research and clinical medicine. This will include responsibility for guiding the activities of the Biomedical Genomics (BIOGEM) laboratory, establishing a Bioinformatics group and overseeing Educational and Philanthropy components of the IGM. I am confident that IGM's success will be further sustained under Dr. Frazer's leadership.

For more information please contact Peggy Bonine (mbonine@ucsd.edu).

David A. Brenner
Vice Chancellor  for Health Sciences and
Dean, School of Medicine